• Home
  • Solutions
    • Cell sourcing
      • Cell therapy starting material
      • Immunogenetics & bioinformatics
      • Personalized case management
    • Cell therapy supply chain
      • Collection network development
      • Cell delivery & logistics
      • Personalized case management
      • MatchSource software
    • Clinical research support
      • Clinical trial design
      • Observational research
      • Biorepository & sample access
    • Collection network management
    • Quality & regulatory services
    • Quality System Audit Program
    • MatchSource software
    • Outcomes data reporting
  • About Us
    • History
    • Leadership
    • Upcoming Events
    • Careers
    • Contact
  • Cell Lines Blog
  • Resources
    • Webinars
    • Industry Insights and White Papers
    • Solution Overviews
  • Newsroom
  • Contact Us
  • Twitter
  • LinkedIn
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
Be The Match BioTherapies®
MENUMENU
  • Solutions
        • Cell sourcing
          • Cell therapy starting material
          • Immunogenetics & bioinformatics
          • Personalized case management
        • Cell therapy supply chain
          • Collection network development
          • Cell delivery & logistics
          • Personalized case management
          • MatchSource software
        • Clinical research support
          • Clinical trial design
          • Observational research
          • Biorepository & sample access
        • Collection network management
        • Outcomes data reporting
        • Quality & regulatory services
        • Quality System Audit Program
        • MatchSource software
  • About Us
    • History
    • Leadership
    • Upcoming Events
    • Careers
    • Contact
  • Cell Lines Blog
  • Resources
    • Webinars
    • Podcast
    • Industry Insights and White Papers
    • Solution Overviews
  • Newsroom
  • Contact Us
Menu
Cell Lines

Be The Match BioTherapies Continues Expansion Internationally

Organization announces plans to build an international network to support the cell and gene therapy industry

Be The Match BioTherapies · Industry Updates, Standardization · September 17, 2018

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

As the cell and gene therapy industry rapidly advances across the United States, Europe and beyond, developing international standards has become an urgent need.

To further support the industry on a global scale, Be The Match BioTherapies® has announced plans for an expansion to Europe, including the launch of a new partnership with Cellex Cell Professionals to build international standards for the cell therapy industry. Under the agreement, the two organizations will partner to develop and deploy an international cell collection network, and to create and implement standards to ease the burden on apheresis and collection infrastructure across Europe.

In addition, Be The Match BioTherapies appointed an International Collection Network Manager, Petr Machalik, who will be responsible for strengthening and growing our vast collection center network.

According to Julie Smolich, our Senior Vice President of Product Delivery and Development, these international initiatives are a significant milestone in Be The Match BioTherapies’ broader efforts to define standards for the industry. “We look forward to working with our partners at Cellex to accelerate the development of international standards that will ease the growing strain on apheresis centers and transplant centers, and help ensure high-quality starting material so that patients can have the best outcomes possible,” she said.

Read the full news release >


Collection Network Development & Management

Learn more about partnering with Be The Match BioTherapies for the development and management of your cell collection network.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
Tags
Collection networkInternational ExpansionNewsstandardization
About the Author
Be The Match BioTherapies

Be The Match BioTherapies

Be The Match BioTherapies partners with organizations pursuing life-saving cellular therapies in every stage of development – from discovery through commercialization. Built on the foundation established over the last 30 years by the National Marrow Donor Program (NMDP)/Be The Match, we have unparalleled experience managing cellular therapies. Our cell therapy supply chain delivery for autologous or allogeneic therapies is enabled by high-touch, personalized case management and a robust, customizable technology platform, MatchSource®. Our experience in cell sourcing and collection allows us to provide cells consented for research, clinical or commercial use. Researchers have access to clinical trial services through our research program CIBMTR. And, we have the infrastructure in place to collect, store and analyze patient samples post-cell or gene therapy treatment at the time points required by regulatory authorities.

More Posts →

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

Close
Be The Match Biotherapies®
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
  • Contact

Copyright © 2019 Be The Match BioTherapies. All Rights Reserved.

  • bethematch.org →

    Information and support for patients, donors and supporters of our mission.

  • bethematchclinical.org →

    The latest transplant information for Clinicians, Network, Payers and Bioinformatics.

  • cibmtr.org →

    Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.